Citalopram, Hydrobromide Salt is a selective inhibitor of the ST (5-hydroxytryptamine transporter) (serotonin) and therefore is a potent and selective serotonin reuptake inhibitor. Additional studies in indicate that Citalopram may be a weak, allosteric modulator of serotonin in a cross-species chimeric study. Studies also indicate that Citalopram is useful for studying gene expression patterns in circulating lymphocytes. In zebrafish, Citalopram is noted to reduce the frequency of NMDA-induced locomotor rhythm involved in swimming behavior.
1. Torres, G.E., et al. 2003. Nat. Rev. Neurosci. 4: 13-25. PMID: 12511858
2. Palotás, A., et al. 2004. Neurochem. Res. 29: 1563-1570. PMID: 15260135
3. Neubauer, H.A., et al. 2006. Mol. Pharmacol. 69: 1242-1250. PMID: 16434615
4. Gabriel, J.P., et al. 2009. J. Neurosci. 29: 10387-10395. PMID: 19692613
See how others have used Citalopram, Hydrobromide Salt. Click on the entry to view the PubMed entry .
PMID: # 26338061 Krasulova, K. et al. 2016. Xenobiotica. 46: 315-24.
PMID: # 24045971 Chae, YJ. et al. 2014. Naunyn Schmiedebergs Arch. Pharmacol. 387: 23-32.
PMID: # 23751335 Writer, JH. et al. 2013. Sci. Total Environ. 461-462: 519-27.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.